Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Kallikrein-related peptidase 4 (KLK4) is a serine protease enzyme involved in enamel formation during tooth development. It is also implicated in cancer progression and endometriosis. KLK4 facilitates the degradation and removal of enamel matrix proteins. Aberrant expression is observed in certain cancers and may promote proliferation and invasion. It is considered a potential therapeutic target, and its expression patterns can serve as a biomarker for certain cancers.
Serine-type endopeptidase; target for inhibitors
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Kallikrein-related peptidase 4 (KLK4).